Position in LNTH
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,619,724
+$561,541 QoQ
Shares Held
14,600
+4.7% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#182
of 466 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $14,352,616 across 10 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
432,956 | $6,940,284 | |
| 2 | LQDA |
Liquidia Corp
|
22,739 | $1,812,980 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
This page
|
14,600 | $1,619,724 | |
| 4 | ZTS |
Zoetis Inc.
|
14,835 | $1,066,043 | |
| 5 | HROW |
Harrow, Inc.
|
24,067 | $1,022,125 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
11,272 | $532,827 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
112,314 | $467,226 | |
| 8 | HLN |
Haleon plc
|
40,539 | $378,228 |
All Filings in LNTH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,619,724 | 14,600 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,058,183 | 13,951 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $770,848 | 11,583 | Shares | Sole | 2026-02-09 | |
| 2024-12-31 | $200,122 | 2,237 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $231,353 | 2,108 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||